Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

NCT00076180 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

NIH

Sponsor class

Conditions

T-Cell Large Granular Lymphocytic Leukemia
Leukemia, T-Cell Large Granular Lymphocytic

Interventions

BIOLOGICAL: Hu-MiK-Beta-1

Sponsor

National Cancer Institute (NCI)